Risk assessment

AI risk assessments often stall innovation when unclear ownership and inconsistent evidence requirements create bottlenecks. Business leaders must own AI risk decisions, supported by clear triage and third-party evidence standards to speed value delivery without compromising controls.

The FCA's 2026 AI Live Testing cohort and Supercharged Sandbox show how Barclays, Experian, Lloyds Banking Group, UBS and other firms are building evidence through controlled testing. NIST's tailorable AI RMF Playbook provides a practical basis for proportionate triage.

Generic vendor privacy assessments couldn't have flagged what happened at MediSecure or Latitude Financial — and that's the problem. This piece uses real breach and enforcement outcomes to show why a signed-off checklist isn't AI privacy control, and sets out the questions every organisation should be asking its AI vendors now.

Unclear ownership and weak third-party evidence can stall AI initiatives for months. This article explains why business-led accountability and structured evidence checklists are critical to smooth AI risk management and faster decision-making.

The UK's new Critical Third Parties regime — covering AWS, Microsoft, Google Cloud and Oracle — signals that strong AI vendor oversight is becoming the new baseline for trust. Organisations that build this capability now, ahead of the curve, stand to gain faster vendor decisions, stronger customer confidence and far fewer surprises.

Third-party AI vendor risk is the widest compliance gap in Australian companies, your vendor's model update is now a regulatory event.

APRA's and ASICs AI governance letters have made one thing clear: named business ownership of AI use cases is now the regulatory minimum. Without it, your organisation is carrying unquantified executive risk.

AI risk management is often seen as a defensive exercise, but this mindset limits business value and slows innovation. Leaders must reframe AI risk as a tool to enable success, balancing risk with opportunity through clear ownership, tailored evidence, and ongoing assurance.